首页 / 资讯详情
When AI designs a drug, who gets the credit?
摘要
When the biotech company Insilico Medicine used its computer models to propose a promising drug for pulmonary fibrosis, it enthusiastically claimed in a press release that the molecule had been “discovered by” its generative AI platform. Insilico leads a pack of companies using AI to rapidly come up with drug ideas humans might never think…
本站为资讯聚合平台，仅展示标题与摘要，原文版权归原发布方所有；如有侵权请联系我们删除。